The majority of these mutations identified in familial breast cancer result in the partial or complete deletion of exons or intronic sequence inserts, which may ultimately yield non-functional, truncated BRCA1 and BRCA2 proteins (2). The gene discussed is BRCA1; the disease is breast cancer.